Reporting of HRQoL results from the PALOMA-2 trial: Relevant data are still missing.

Ann Oncol · 2018 · PMC6096735 · PMID 29873692

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

Key conclusions include: a positive trend (HR <1) favouring the palbociclib arm for time to deterioration (TTD) in HRQoL; a significantly greater improvement in pain scores in the palbociclib plus letrozole arm; the value of radiological assessments in estimating treatment effects on HRQoL.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.